• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用人诱导多能干细胞衍生的心肌细胞建立缺血性心力衰竭的体外模型。

In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes.

机构信息

Frankel Cardiovascular Regeneration Core Laboratory, Department of Internal Medicine, Division of Cardiovascular Medicine.

Center for Arrhythmia Research.

出版信息

JCI Insight. 2021 May 24;6(10):134368. doi: 10.1172/jci.insight.134368.

DOI:10.1172/jci.insight.134368
PMID:33878037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8262347/
Abstract

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have been used extensively to model inherited heart diseases, but hiPSC-CM models of ischemic heart disease are lacking. Here, our objective was to generate an hiPSC-CM model of ischemic heart disease. To this end, hiPSCs were differentiated into functional hiPSC-CMs and then purified using either a simulated ischemia media or by using magnetic antibody-based purification targeting the nonmyocyte population for depletion from the cell population. Flow cytometry analysis confirmed that each purification approach generated hiPSC-CM cultures that had more than 94% cTnT+ cells. After purification, hiPSC-CMs were replated as confluent syncytial monolayers for electrophysiological phenotype analysis and protein expression by Western blotting. The phenotype of metabolic stress-selected hiPSC-CM monolayers recapitulated many of the functional and structural hallmarks of ischemic CMs, including elevated diastolic calcium, diminished calcium transient amplitude, prolonged action potential duration, depolarized resting membrane potential, hypersensitivity to chemotherapy-induced cardiotoxicity, depolarized mitochondrial membrane potential, depressed SERCA2a expression, reduced maximal oxygen consumption rate, and abnormal response to β1-adrenergic receptor stimulation. These findings indicate that metabolic selection of hiPSC-CMs generated cell populations with phenotype similar to what is well known to occur in the setting of ischemic heart failure and thus provide a opportunity for study of human ischemic heart disease.

摘要

人诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)已被广泛用于模拟遗传性心脏病,但缺血性心脏病的 hiPSC-CM 模型仍然缺乏。在这里,我们的目标是生成缺血性心脏病的 hiPSC-CM 模型。为此,将 hiPSC 分化为功能性 hiPSC-CM,然后使用模拟缺血介质或使用针对非心肌细胞群的基于磁性抗体的纯化方法从细胞群中去除来进行纯化。流式细胞术分析证实,每种纯化方法都产生了超过 94% cTnT+细胞的 hiPSC-CM 培养物。纯化后,将 hiPSC-CM 重新铺板为融合的合胞单层,以进行电生理表型分析和通过 Western blot 进行蛋白质表达分析。代谢应激选择的 hiPSC-CM 单层的表型再现了许多缺血性 CM 的功能和结构特征,包括升高的舒张钙、钙瞬变幅度降低、动作电位持续时间延长、静息膜电位去极化、对化疗诱导的心脏毒性敏感性增加、线粒体膜电位去极化、SERCA2a 表达降低、最大耗氧量降低以及对β1-肾上腺素能受体刺激的异常反应。这些发现表明,代谢选择 hiPSC-CM 生成的细胞群体具有与已知在缺血性心力衰竭情况下发生的表型相似的表型,从而为研究人类缺血性心脏病提供了机会。

相似文献

1
In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes.利用人诱导多能干细胞衍生的心肌细胞建立缺血性心力衰竭的体外模型。
JCI Insight. 2021 May 24;6(10):134368. doi: 10.1172/jci.insight.134368.
2
Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.人诱导多能干细胞衍生的非心肌细胞通过缝隙连接蛋白 43 介导的细胞间相互作用调节心脏电生理成熟。
Stem Cells Dev. 2020 Jan 15;29(2):75-89. doi: 10.1089/scd.2019.0098. Epub 2019 Dec 16.
3
Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells.人诱导多能干细胞来源的交感神经元和心肌细胞的功能共培养。
Am J Physiol Heart Circ Physiol. 2020 Nov 1;319(5):H927-H937. doi: 10.1152/ajpheart.00546.2020. Epub 2020 Aug 21.
4
CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.CCND2 过表达增强了人诱导多能干细胞衍生心肌细胞的再生能力:损伤心室的再肌化。
Circ Res. 2018 Jan 5;122(1):88-96. doi: 10.1161/CIRCRESAHA.117.311504. Epub 2017 Oct 10.
5
Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.人多能干细胞来源的心肌细胞的结构和功能成熟。
Stem Cells Dev. 2013 Jul 15;22(14):1991-2002. doi: 10.1089/scd.2012.0490. Epub 2013 Apr 5.
6
Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.心肌收缩调节对人诱导多能干细胞衍生心肌细胞的急性影响。
Physiol Rep. 2021 Nov;9(21):e15085. doi: 10.14814/phy2.15085.
7
Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.靶向 HIF-1α 与 PPARα 激活和出生后因素相结合可促进人诱导多能干细胞衍生心肌细胞的代谢成熟。
J Mol Cell Cardiol. 2019 Jul;132:120-135. doi: 10.1016/j.yjmcc.2019.05.003. Epub 2019 May 11.
8
Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.基于人诱导多能干细胞(hiPSC)分化的心肌细胞和心脏细胞外基质构建的工程化心脏组织模型,可用于疾病建模和药物测试应用。
Acta Biomater. 2019 Jul 1;92:145-159. doi: 10.1016/j.actbio.2019.05.016. Epub 2019 May 7.
9
Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes.三碘甲状腺原氨酸和地塞米松改变钾通道表达并促进人诱导多能干细胞衍生心肌细胞的电生理成熟。
J Mol Cell Cardiol. 2021 Dec;161:130-138. doi: 10.1016/j.yjmcc.2021.08.005. Epub 2021 Aug 13.
10
Electrical stimulation applied during differentiation drives the hiPSC-CMs towards a mature cardiac conduction-like cells.电刺激在分化过程中施加,可将 hiPSC-CMs 推向成熟的心脏传导样细胞。
Biochem Biophys Res Commun. 2020 Dec 10;533(3):376-382. doi: 10.1016/j.bbrc.2020.09.021. Epub 2020 Sep 19.

引用本文的文献

1
Healthy human induced pluripotent stem cell-derived cardiomyocytes exhibit sex dimorphism even without the addition of hormones.健康的人类诱导多能干细胞衍生的心肌细胞即使在不添加激素的情况下也表现出性别二态性。
Stem Cells. 2025 Jun 20. doi: 10.1093/stmcls/sxaf038.
2
AI-guided laser purification of human iPSC-derived cardiomyocytes for next-generation cardiac cell manufacturing.用于下一代心脏细胞制造的人工智能引导的人诱导多能干细胞衍生心肌细胞激光纯化
Commun Biol. 2025 May 13;8(1):745. doi: 10.1038/s42003-025-08162-0.
3
Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the Heart Failure Association of the ESC.

本文引用的文献

1
Detection of Drug-Induced Torsades de Pointes Arrhythmia Mechanisms Using hiPSC-CM Syncytial Monolayers in a High-Throughput Screening Voltage Sensitive Dye Assay.应用 hiPSC-CM 合胞单层在高通量筛选电压敏感染料测定中检测药物诱导的尖端扭转型室性心动过速心律失常机制。
Toxicol Sci. 2020 Feb 1;173(2):402-415. doi: 10.1093/toxsci/kfz235.
2
Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors.通过第二心区祖细胞由人多能干细胞分化而来的功能性心肌成纤维细胞。
Nat Commun. 2019 May 20;10(1):2238. doi: 10.1038/s41467-019-09831-5.
3
Muscle-specific stress fibers give rise to sarcomeres in cardiomyocytes.
在转化心血管研究中使用人类样本的机遇与挑战:欧洲心脏病学会心脏细胞生物学工作组、欧洲心脏病学会心血管外科工作组、欧洲心脏病学会基础心血管科学委员会、欧洲心脏病学会明日科学家、欧洲心脏病学会经皮心血管介入治疗协会以及欧洲心脏病学会心力衰竭协会的科学声明
Cardiovasc Res. 2025 May 23;121(5):702-729. doi: 10.1093/cvr/cvaf023.
4
Cardiac-targeted delivery of a novel Drp1 inhibitor for acute cardioprotection.一种新型动力蛋白1(Drp1)抑制剂的心脏靶向递送用于急性心脏保护
J Mol Cell Cardiol Plus. 2024 Jul 17;9:100085. doi: 10.1016/j.jmccpl.2024.100085. eCollection 2024 Sep.
5
Advancing 3D Engineered In Vitro Models for Heart Failure Research: Key Features and Considerations.推进用于心力衰竭研究的3D工程体外模型:关键特征与注意事项
Bioengineering (Basel). 2024 Dec 3;11(12):1220. doi: 10.3390/bioengineering11121220.
6
The Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity.现实心脏模型在疾病建模和心脏毒性研究中的应用现状。
Int J Mol Sci. 2024 Aug 24;25(17):9186. doi: 10.3390/ijms25179186.
7
Bipolar Patient-Specific In Vitro Diagnostic Test Reveals Underlying Cardiac Arrhythmia Phenotype Caused by Calcium Channel Genetic Risk Factor.双相情感障碍患者特异性体外诊断测试揭示了由钙通道遗传风险因素引起的潜在心律失常表型。
Biol Psychiatry Glob Open Sci. 2024 Feb 20;4(3):100296. doi: 10.1016/j.bpsgos.2024.100296. eCollection 2024 May.
8
In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC cardiomyocytes.在体研究 hiPSC 心肌细胞缺血再灌注过程中缺氧和收缩功能障碍的机制。
Dis Model Mech. 2024 Apr 1;17(4). doi: 10.1242/dmm.050365. Epub 2024 Apr 26.
9
In situ monolayer patch clamp of acutely stimulated human iPSC-derived cardiomyocytes promotes consistent electrophysiological responses to SK channel inhibition.急性刺激人诱导多能干细胞衍生的心肌细胞的原位单层膜片钳技术促进了对 SK 通道抑制的一致电生理反应。
Sci Rep. 2024 Feb 7;14(1):3185. doi: 10.1038/s41598-024-53571-6.
10
FRESH™ 3D bioprinted cardiac tissue, a bioengineered platform for pharmacology.FRESH™ 3D生物打印心脏组织,一种用于药理学的生物工程平台。
APL Bioeng. 2023 Dec 1;7(4):046113. doi: 10.1063/5.0163363. eCollection 2023 Dec.
肌节特异性应激纤维在心肌细胞中产生。
Elife. 2018 Dec 12;7:e42144. doi: 10.7554/eLife.42144.
4
New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides.心力衰竭中 SERCA2a 基因治疗的新见解:关注 B 型利钠肽的负面效应。
J Med Genet. 2018 May;55(5):287-296. doi: 10.1136/jmedgenet-2017-105120. Epub 2018 Feb 24.
5
hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen.人诱导多能干细胞心肌细胞单层成熟状态决定高通量致心律失常药物筛选中的药物反应性。
Sci Rep. 2017 Oct 23;7(1):13834. doi: 10.1038/s41598-017-13590-y.
6
Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes.高效的人类诱导多能干细胞二维大规模培养系统及分化的心肌细胞。
Stem Cell Reports. 2017 Nov 14;9(5):1406-1414. doi: 10.1016/j.stemcr.2017.08.025. Epub 2017 Oct 5.
7
Chronic Myocardial Ischemia Leads to Loss of Maximal Oxygen Consumption and Complex I Dysfunction.慢性心肌缺血导致最大耗氧量丧失和复合体I功能障碍。
Ann Thorac Surg. 2017 Oct;104(4):1298-1304. doi: 10.1016/j.athoracsur.2017.03.004. Epub 2017 Jun 1.
8
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.
9
Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.在疾病特异性人类胚胎干细胞衍生的心肌细胞中,心肌细胞分化过程中cMyBP-C蛋白表达不足是人类肥厚型心肌病细胞表型的基础。
J Mol Cell Cardiol. 2016 Oct;99:197-206. doi: 10.1016/j.yjmcc.2016.09.004. Epub 2016 Sep 10.
10
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.人诱导多能干细胞衍生的心肌细胞重现了乳腺癌患者对阿霉素诱导的心脏毒性的易感性。
Nat Med. 2016 May;22(5):547-56. doi: 10.1038/nm.4087. Epub 2016 Apr 18.